Thermo Fisher Scientific | TMO - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Abbott USD 52.06B 69M 2026-03
Agilent USD 7.36B 241M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio Techne USD 2.11B 22.92M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Bruker USD 2.44B 67M 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Henry Schein USD 3.16B 109M 2026-06
Illumina USD 2.84B 162M 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Medtronic USD 50.07B 1.09B 2026-03
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
Olympus JPY 747.9B 64.14B 2026-06
OraSure Technologies USD 317.78M 4.45M 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Repligen USD 2.11B 6.57M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Stryker USD 22.98B 559M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Veracyte USD 1.39B 44M 2026-06
Waters USD 15.29B 12.73B 2026-03
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06